Case Studies in Bayesian Methods for Biopharmaceutical CMC Case Studies in Bayesian Methods for Biopharmaceutical CMC
Chapman & Hall/CRC Biostatistics Series

Case Studies in Bayesian Methods for Biopharmaceutical CMC

    • $72.99
    • $72.99

Publisher Description

The subject of this book is applied Bayesian methods for chemistry, manufacturing, and control (CMC) studies in the biopharmaceutical industry. The book has multiple authors from industry and academia, each contributing a case study (chapter). The collection of case studies covers a broad array of CMC topics, including stability analysis, analytical method development, specification setting, process development and optimization, process control, experimental design, dissolution testing, and comparability studies. The analysis of each case study includes a presentation of code and reproducible output. This book is written with an academic level aimed at practicing nonclinical biostatisticians, most of whom have graduate degrees in statistics.

• First book of its kind focusing strictly on CMC Bayesian case studies

• Case studies with code and output

• Representation from several companies across the industry as well as academia

• Authors are leading and well-known Bayesian statisticians in the CMC field

• Accompanying website with code for reproducibility

• Reflective of real-life industry applications/problems

GENRE
Science & Nature
RELEASED
2022
December 15
LANGUAGE
EN
English
LENGTH
354
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
30.5
MB
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Signal Detection for Medical Scientists Signal Detection for Medical Scientists
2021
Bayesian Designs for Phase I-II Clinical Trials Bayesian Designs for Phase I-II Clinical Trials
2017
Comparative Effectiveness and Personalized Medicine Research Using Real-World Data Comparative Effectiveness and Personalized Medicine Research Using Real-World Data
2026
Dose-Exposure-Response Modeling Dose-Exposure-Response Modeling
2026